CATALINA MALDONADO: Open Payments
NPI 1679320345 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 54 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $220 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $200 |
| Amgen Inc. | 10 | $197 |
| Novo Nordisk Inc | 5 | $126 |
| Mallinckrodt Hospital Products Inc. | 1 | $125 |
| PFIZER INC. | 5 | $118 |
| SCPHARMACEUTICALS INC. | 4 | $95 |
| Lilly USA, LLC | 4 | $93 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
Products named: REPATHA, LEQVIO, TERLIVAZ, ELIQUIS, FUROSCIX, ZEPBOUND, Rybelsus, VERQUVO.
Industry payments across NY — which companies pay providers there.
